[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Romond et al., 1997 - Google Patents

Cell-free wheys from bifidobacteria fermented milks exert a regulatory effect on the intestinal microflora of mice and humans

Romond et al., 1997

View PDF
Document ID
13675568529264127390
Author
Romond M
Ais A
Yazourh A
Romond C
Publication year
Publication venue
Anaerobe

External Links

Snippet

Bacteroides fragilisand clostridia are normally present in the human colon but they may exert pathogenic effects when the homeostasis is upset following various forms of stress. One approach to preventing gastrointestinal disorders is to use bifidobacteria fermented …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—PROCESSES USING MICRO-ORGANISMS
    • C12R1/00—Processes using micro-organisms
    • C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
US5709857A (en) Lactobacillus strains of human origin, their compositons and uses thereof
Romond et al. Cell-free whey from milk fermented with Bifidobacterium breve C50 used to modify the colonic microflora of healthy subjects
EP0508701B1 (en) Probiotic
Du Toit et al. Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content
JP4706016B2 (en) Bifidobacterium in the treatment of inflammatory diseases
Ohkusa et al. Long-Term Ingestion of LactosucroseIncreases Bifidobacterium sp. in Human Fecal Flora
Guglielmotti et al. Probiotic potential of Lactobacillus delbrueckii strains and their phage resistant mutants
Garvie et al. The effect of yoghurt on some components of the gut microflora and on the metabolism of lactose in the rat
EP1816190B1 (en) New lactic bacteria useful as probiotics
JP2992945B2 (en) Lactobacillus acidophilus lactic acid bacteria
KR102166461B1 (en) Lactobacillus rhamnosus strain having intestinal immunomodulatory function and preventive or therapeutic activity for inflammatory bowel disease
US20040038379A1 (en) Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom
US4588595A (en) Culture containing a viable cell mass of Bifidobacteria and lactic acid bacteria
Ale et al. Functional properties of exopolysaccharide (EPS) extract from Lactobacillus fermentum Lf2 and its impact when combined with Bifidobacterium animalis INL1 in yoghurt
JP4456160B2 (en) Novel lactic acid strains and their use
Romond et al. Cell-free wheys from bifidobacteria fermented milks exert a regulatory effect on the intestinal microflora of mice and humans
KR100794702B1 (en) Microorganisms which are taken effects in preventing and/or treating Obesity or Diabetes Mellitus
Pato et al. Hypocholesterolemic effect of indigenous dadih lactic acid bacteria by deconjugation of bile salts
Chaia et al. Dairy propionibacteria from milk or cheese diets remain viable and enhance propionic acid production in the mouse cecum
Sakai et al. Mortality of bifidobacteria in boiled yogurt
Mullié et al. Partial characterization of Bifidobacterium breve C50 cell-free whey compounds inducing modifications to the intestinal microflora
JP3384907B2 (en) New bifidobacteria and their use
Muhammad et al. Evaluation of probiotics potential of Lactobacilli isolated from Chinese traditional dairy products.
Shweta et al. In vitro studies on anti-inflammatory, antioxidant and antihyperglycemic activities of potential probiotic Pediococcus acidilactici NCDC 252
Romond et al. Colonization of the murine gut by Bifidobacterium bifidum and Clostridium perfringens during ageing